| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.3B | $39.3B | $41.3B | $33.8B | $12.2B | $10.7B | $2.9B | $10.6B |
| Cost of Revenue | — | — | — | — | — | — | — | $3.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $9.4B | $9.3B | $9.7B | $9.7B | $4.0B | $2.7B | $2.8B | $2.6B |
| Operating Income | $0.7B | $-10.0B | $-1.5B | $-7.4B | $2.0B | $2.5B | $0.7B | $0.7B |
| Net Income | $0.7B | $-11.3B | $-3.1B | $-7.4B | $1.0B | $1.2B | $0.5B | $0.3B |
| EPS (Basic) | $0.29 | $-4.62 | $-1.28 | $-3.82 | — | — | — | — |
| EPS (Diluted) | $0.29 | $-4.62 | $-1.28 | $-3.82 | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $100.1B | $104.6B | $122.8B | $134.0B | $34.4B | $34.1B | $33.7B | $32.5B |
| Current Assets | $13.2B | $14.1B | $14.2B | $14.0B | $7.3B | $6.1B | $5.2B | $4.2B |
| Cash & Equivalents | $4.6B | $5.3B | $3.8B | $3.7B | $3.9B | $2.1B | $1.6B | $1.0B |
| Total Liabilities | $62.9B | $69.6B | $76.3B | $85.3B | $21.0B | $21.7B | $21.8B | $22.0B |
| Current Liabilities | $12.5B | $15.8B | $15.3B | $15.0B | $3.5B | $3.1B | $3.2B | $4.0B |
| Stockholders' Equity | $35.9B | $34.0B | $45.2B | $47.1B | $11.6B | $10.5B | $9.9B | $8.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.3B | $5.4B | $7.5B | $4.3B | $2.8B | $2.7B | $3.4B | $2.6B |
| Investing Cash Flow | $-1.2B | $-0.3B | $-1.3B | $3.5B | $-0.1B | $-0.7B | $-0.4B | $-8.6B |
| Capital Expenditures | $1.2B | $0.9B | $1.3B | $1.0B | $0.4B | $0.4B | $0.3B | $0.1B |
| Financing Cash Flow | $-4.2B | $-3.7B | $-5.8B | $-7.7B | $-0.9B | $-1.5B | $-2.4B | $-0.3B |